Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T20:46:45.398Z Has data issue: false hasContentIssue false

18 - HIV infection

from Part II - Neurological diseases

Published online by Cambridge University Press:  29 September 2009

Albert Hofman
Affiliation:
Erasmus Universiteit Rotterdam
Richard Mayeux
Affiliation:
Columbia University, New York
Get access

Summary

Introduction

Human immunodeficiency virus (HIV) infection has expanded to become a global pandemic which threatens health in most areas of the world, and is now the leading cause of death among some segments of the population. For example, in 1995 in the USA, AIDS surpassed cancer as the predominant cause of death in young African–American women (25–44 years). From the beginning of the epidemic through to 31 December 1997, there have been 641,086 cases of AIDS and 390,692 AIDS deaths in the USA, according to the Centers for Disease Control (CDC). Rates in women, children, and injecting drug users (IDUs) and infection through heterosexual contact have been rising. In the USA in 1996, African–Americans represented 41% of adults/adolescents reported with AIDS, exceeding the proportion who are Caucasians for the first time. On a worldwide scale, the World Health Organization (WHO) has estimated that, as of the end of 1995, 6 million AIDS cases and approximately 20 million people were alive and infected with the HIV-1 virus. WHO estimates that nearly 10,000 new infections occur each day.

For the first time since the beginning of the epidemic, the number of AIDS deaths in the USA declined by 13% in the first half of 1996 compared to 1995. Most of the dramatic change, however, was seen among Caucasian homosexual males, and women and minorities continued to show increases in AIDS death rates. The factors explaining this discrepancy probably reflect restricted access for these groups to medical care, and particularly to the newer combination antiretroviral therapies.

Type
Chapter
Information
Investigating Neurological Disease
Epidemiology for Clinical Neurology
, pp. 246 - 258
Publisher: Cambridge University Press
Print publication year: 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×